APG Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$236M Buy
1,248,938
+117,344
+10% +$26M 0.75% 25
2025
Q4
$220M Sell
1,131,594
-88,543
-7% -$20.2M 0.62% 29
2025
Q3
$240M Sell
1,220,137
-276,886
-18% -$56.4M 0.67% 29
2025
Q2
$237M Sell
1,497,023
-310,196
-17% -$57.6M 0.7% 26
2025
Q1
$351M Buy
1,807,219
+38,372
+2% +$7.46M 1.09% 16
2024
Q4
$304M Buy
1,768,847
+1,432,074
+425% +$263M 0.85% 24
2024
Q3
$59.6M Sell
336,773
-1,414,300
-81% -$264M 0.4% 38
2024
Q2
$280M Buy
1,751,073
+15,962
+0.9% +$2.64M 0.5% 44
2024
Q1
$293M Sell
1,735,111
-93,632
-5% -$16.1M 0.51% 43
2023
Q4
$257M Sell
1,828,743
-13,791
-0.7% -$2.01M 0.5% 46
2023
Q3
$275M Sell
1,842,534
-166,097
-8% -$24.4M 0.56% 41
2023
Q2
$248M Sell
2,008,631
-52,451
-3% -$7.69M 0.5% 40
2023
Q1
$302M Sell
2,061,082
-333,553
-14% -$51M 0.64% 34
2022
Q4
$387M Buy
2,394,635
+1,921,157
+406% +$295M 0.74% 29
2022
Q3
$64.9M Buy
473,478
+128,602
+37% +$18.5M 0.17% 147
2022
Q2
$50.5M Buy
344,876
+68,661
+25% +$10.5M 0.12% 208
2022
Q1
$40.2M Sell
276,215
-74,505
-21% -$10.8M 0.08% 261
2021
Q4
$41.8M Buy
350,720
+43,098
+14% +$5.09M 0.07% 271
2021
Q3
$28.6M Sell
307,622
-64,300
-17% -$7.35M 0.05% 332
2021
Q2
$35.3M Sell
371,922
-179,717
-33% -$20.2M 0.06% 323
2021
Q1
$50.8M Sell
551,639
-440,921
-44% -$47.2M 0.09% 267
2020
Q4
$86.9M Sell
992,560
-699,791
-41% -$67.2M 0.14% 176
2020
Q3
$126M Sell
1,692,351
-300,969
-15% -$28.3M 0.22% 118
2020
Q2
$174M Buy
1,993,320
+250,096
+14% +$22M 0.32% 76
2020
Q1
$133M Buy
1,743,224
+1,025,112
+143% +$87.3M 0.26% 101
2019
Q4
$56.6M Buy
718,112
+52,600
+8% +$4.37M 0.09% 247
2019
Q3
$46.2M Buy
665,512
+5,629
+0.9% +$386K 0.08% 283
2019
Q2
$42.1M Buy
659,883
+141,700
+27% +$11.1M 0.07% 281
2019
Q1
$37.2M Sell
518,183
-2,638,100
-84% -$216M 0.07% 292
2018
Q4
$255M Buy
3,156,283
+506,700
+19% +$44.6M 0.52% 48
2018
Q3
$216M Buy
2,649,583
+290,500
+12% +$27.5M 0.38% 75
2018
Q2
$187M Sell
2,359,083
-15,500
-0.7% -$1.51M 0.34% 89
2018
Q1
$183M Buy
2,374,583
+74,300
+3% +$8.16M 0.35% 86
2017
Q4
$185M Buy
2,300,283
+327,974
+17% +$30.9M 0.34% 87
2017
Q3
$175M Buy
1,972,309
+404,700
+26% +$30.8M 0.29% 102
2017
Q2
$114M Sell
1,567,609
-555,483
-26% -$37.3M 0.21% 153
2017
Q1
$138M Sell
2,123,092
-689,972
-25% -$43.4M 0.25% 116
2016
Q4
$167M Sell
2,813,064
-280,400
-9% -$17.1M 0.31% 75
2016
Q3
$195M Hold
3,093,464
0.34% 66
2016
Q2
$192M Buy
3,093,464
+142,600
+5% +$8.69M 0.36% 74
2016
Q1
$169M Buy
2,950,864
+391,277
+15% +$21.8M 0.35% 76
2015
Q4
$152M Sell
2,559,587
-163,305
-6% -$9.41M 0.35% 77
2015
Q3
$148M Sell
2,722,892
-242,024
-8% -$15.8M 0.34% 84
2015
Q2
$199M Buy
2,964,916
+52,606
+2% +$3.43M 0.4% 59
2015
Q1
$170M Buy
2,912,310
+16,267
+0.6% +$983K 0.35% 77
2014
Q4
$190M Sell
2,896,043
-369,656
-11% -$23.3M 0.36% 73
2014
Q3
$189M Sell
3,265,699
-188,710
-5% -$10.5M 0.38% 59
2014
Q2
$195M Buy
3,454,409
+385,074
+13% +$20.2M 0.42% 52
2014
Q1
$158M Buy
3,069,335
+195,644
+7% +$9.89M 0.41% 58
2013
Q4
$152M Sell
2,873,691
-1,008,004
-26% -$49.5M 0.45% 53
2013
Q3
$174M Sell
3,881,695
-680,540
-15% -$30.2M 0.55% 35
2013
Q2
$189M Buy
+4,562,235
New +$200M 0.59% 31

Other funds holding ABBV

APG Asset Management's ABBV Position: Q1 2026 in Review

APG Asset Management increased its AbbVie (ABBV) stake by 10% in Q1 2026, buying an estimated $26M and bringing the position to 1,248,938 shares worth $236M. The position accounts for 0.75% of the portfolio, ranked #25.

APG Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $387M in Q4 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • APG Asset Management held 1,248,938 shares of AbbVie worth $236M as of Q1 2026.
  • APG Asset Management bought 117,344 AbbVie shares in Q1 2026, an estimated $26M.
  • AbbVie made up 0.75% of APG Asset Management's portfolio in Q1 2026, its #25 holding.
  • APG Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • APG Asset Management's AbbVie position peaked at $387M in Q4 2022.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on APG Asset Management's 13F filing for Q1 2026, filed 13 May 2026.